SGLT-2 Inhibition Guideline for REVIEW
The draft UK Kidney Association clinical practice guideline on Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease is now available for review.
Please send any comments to Sarah Crimp by Sunday 12 September, using this form
Expressions of interest sought: Commentary on KDIGO blood pressure in CKD guideline
Expressions of interest are invited to write a commentary on the KDIGO 2021 Clinical Practice Guideline on the Management of Blood Pressure (BP) in Chronic Kidney Disease (CKD).
The commentary will be added to the Renal Association commentary on the NICE guideline ‘Hypertension in adults: diagnosis and management’ (NG136), published in March 2021, rather than producing a second document.
To apply please send a short statement of no more than one side of A4 explaining why you would like to be involved, along with a completed conflict of interest form to sarah.crimp@renal.org by Sunday 12th September 2021.
